TeNor Therapeutics (丹诺医药) Pre-IPO Quick Comment: Strong Innovation Constrained by Commercial Outlook
Tenor Therapeutics has Innovative antibacterial assets with solid clinical rationale, but commercialization faces structural headwinds from...
386 Views
Pre-IPO TenNor Therapeutics (Suzhou) Limited - The Pipelines and the Concerns
China has vigorously restricted the use of antibiotics.TenNor's product won’t replace old ones completely due to higher price/difficulty of...
494 Views